Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials.
Identifieur interne : 001C76 ( PubMed/Corpus ); précédent : 001C75; suivant : 001C77Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials.
Auteurs : P D Le Coutre ; T P Hughes ; F-X Mahon ; D-W Kim ; J L Steegmann ; N P Shah ; K. Gooden ; N. Wallis ; J E CortesSource :
- Leukemia [ 1476-5551 ] ; 2016.
DOI: 10.1038/leu.2015.352
PubMed: 26686247
Links to Exploration step
pubmed:26686247Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials.</title>
<author><name sortKey="Le Coutre, P D" sort="Le Coutre, P D" uniqKey="Le Coutre P" first="P D" last="Le Coutre">P D Le Coutre</name>
<affiliation><nlm:affiliation>Charité, Campus Virchow Klinikum, Medizinische Klinik m.S. Hämatologie und Onkologie, Universitätsmedizin Berlin, Berlin, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hughes, T P" sort="Hughes, T P" uniqKey="Hughes T" first="T P" last="Hughes">T P Hughes</name>
<affiliation><nlm:affiliation>Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Department of Haematology, SA Pathology, University of Adelaide, Adelaide, South Australia, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mahon, F X" sort="Mahon, F X" uniqKey="Mahon F" first="F-X" last="Mahon">F-X Mahon</name>
<affiliation><nlm:affiliation>Centre Hospitalier Universitaire de Bordeaux, Laboratoire d'Hématologie et Service des Maladies du Sang, Bordeaux et Institut Bergonié, Bordeaux, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kim, D W" sort="Kim, D W" uniqKey="Kim D" first="D-W" last="Kim">D-W Kim</name>
<affiliation><nlm:affiliation>Division of Hematology, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Steegmann, J L" sort="Steegmann, J L" uniqKey="Steegmann J" first="J L" last="Steegmann">J L Steegmann</name>
<affiliation><nlm:affiliation>Department of Hematology and IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shah, N P" sort="Shah, N P" uniqKey="Shah N" first="N P" last="Shah">N P Shah</name>
<affiliation><nlm:affiliation>Department of Medicine, Division of Hematology/Oncology, University of California at San Francisco School of Medicine, San Francisco, CA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gooden, K" sort="Gooden, K" uniqKey="Gooden K" first="K" last="Gooden">K. Gooden</name>
<affiliation><nlm:affiliation>Bristol-Myers Squibb, Princeton, NJ, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wallis, N" sort="Wallis, N" uniqKey="Wallis N" first="N" last="Wallis">N. Wallis</name>
<affiliation><nlm:affiliation>Bristol-Myers Squibb, Princeton, NJ, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cortes, J E" sort="Cortes, J E" uniqKey="Cortes J" first="J E" last="Cortes">J E Cortes</name>
<affiliation><nlm:affiliation>Division of Cancer Medicine, Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26686247</idno>
<idno type="pmid">26686247</idno>
<idno type="doi">10.1038/leu.2015.352</idno>
<idno type="wicri:Area/PubMed/Corpus">001C76</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C76</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials.</title>
<author><name sortKey="Le Coutre, P D" sort="Le Coutre, P D" uniqKey="Le Coutre P" first="P D" last="Le Coutre">P D Le Coutre</name>
<affiliation><nlm:affiliation>Charité, Campus Virchow Klinikum, Medizinische Klinik m.S. Hämatologie und Onkologie, Universitätsmedizin Berlin, Berlin, Germany.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hughes, T P" sort="Hughes, T P" uniqKey="Hughes T" first="T P" last="Hughes">T P Hughes</name>
<affiliation><nlm:affiliation>Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Department of Haematology, SA Pathology, University of Adelaide, Adelaide, South Australia, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mahon, F X" sort="Mahon, F X" uniqKey="Mahon F" first="F-X" last="Mahon">F-X Mahon</name>
<affiliation><nlm:affiliation>Centre Hospitalier Universitaire de Bordeaux, Laboratoire d'Hématologie et Service des Maladies du Sang, Bordeaux et Institut Bergonié, Bordeaux, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kim, D W" sort="Kim, D W" uniqKey="Kim D" first="D-W" last="Kim">D-W Kim</name>
<affiliation><nlm:affiliation>Division of Hematology, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Steegmann, J L" sort="Steegmann, J L" uniqKey="Steegmann J" first="J L" last="Steegmann">J L Steegmann</name>
<affiliation><nlm:affiliation>Department of Hematology and IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Shah, N P" sort="Shah, N P" uniqKey="Shah N" first="N P" last="Shah">N P Shah</name>
<affiliation><nlm:affiliation>Department of Medicine, Division of Hematology/Oncology, University of California at San Francisco School of Medicine, San Francisco, CA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gooden, K" sort="Gooden, K" uniqKey="Gooden K" first="K" last="Gooden">K. Gooden</name>
<affiliation><nlm:affiliation>Bristol-Myers Squibb, Princeton, NJ, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wallis, N" sort="Wallis, N" uniqKey="Wallis N" first="N" last="Wallis">N. Wallis</name>
<affiliation><nlm:affiliation>Bristol-Myers Squibb, Princeton, NJ, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cortes, J E" sort="Cortes, J E" uniqKey="Cortes J" first="J E" last="Cortes">J E Cortes</name>
<affiliation><nlm:affiliation>Division of Cancer Medicine, Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Leukemia</title>
<idno type="eISSN">1476-5551</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">26686247</PMID>
<DateCreated><Year>2016</Year>
<Month>07</Month>
<Day>06</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>30</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5551</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>30</Volume>
<Issue>7</Issue>
<PubDate><Year>2016</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Leukemia</Title>
<ISOAbbreviation>Leukemia</ISOAbbreviation>
</Journal>
<ArticleTitle>Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials.</ArticleTitle>
<Pagination><MedlinePgn>1593-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/leu.2015.352</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>le Coutre</LastName>
<ForeName>P D</ForeName>
<Initials>PD</Initials>
<AffiliationInfo><Affiliation>Charité, Campus Virchow Klinikum, Medizinische Klinik m.S. Hämatologie und Onkologie, Universitätsmedizin Berlin, Berlin, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hughes</LastName>
<ForeName>T P</ForeName>
<Initials>TP</Initials>
<AffiliationInfo><Affiliation>Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Department of Haematology, SA Pathology, University of Adelaide, Adelaide, South Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mahon</LastName>
<ForeName>F-X</ForeName>
<Initials>FX</Initials>
<AffiliationInfo><Affiliation>Centre Hospitalier Universitaire de Bordeaux, Laboratoire d'Hématologie et Service des Maladies du Sang, Bordeaux et Institut Bergonié, Bordeaux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>D-W</ForeName>
<Initials>DW</Initials>
<AffiliationInfo><Affiliation>Division of Hematology, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Steegmann</LastName>
<ForeName>J L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo><Affiliation>Department of Hematology and IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shah</LastName>
<ForeName>N P</ForeName>
<Initials>NP</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology/Oncology, University of California at San Francisco School of Medicine, San Francisco, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gooden</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wallis</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Bristol-Myers Squibb, Princeton, NJ, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cortes</LastName>
<ForeName>J E</ForeName>
<Initials>JE</Initials>
<AffiliationInfo><Affiliation>Division of Cancer Medicine, Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>12</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Leukemia</MedlineTA>
<NlmUniqueID>8704895</NlmUniqueID>
<ISSNLinking>0887-6924</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Vasc Surg. 2007 Jan;45 Suppl S:S5-67</RefSource>
<PMID Version="1">17223489</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2010 Jun 17;362(24):2251-9</RefSource>
<PMID Version="1">20525993</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2013 Jun;27(6):1310-5</RefSource>
<PMID Version="1">23459450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Res. 2005 Jun 1;65(11):4500-5</RefSource>
<PMID Version="1">15930265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2013 Oct 19;382(9901):1329-40</RefSource>
<PMID Version="1">23915883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Scand J Prim Health Care. 1998 Sep;16(3):177-82</RefSource>
<PMID Version="1">9800232</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC4935977</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>12</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26686247</ArticleId>
<ArticleId IdType="pii">leu2015352</ArticleId>
<ArticleId IdType="doi">10.1038/leu.2015.352</ArticleId>
<ArticleId IdType="pmc">PMC4935977</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C76 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001C76 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:26686247 |texte= Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26686247" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |